Overview of pharmacoeconomic modelling methods-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Overview of pharmacoeconomic modelling methods

Published:2013-03-15 Issue:4 Volume:75 Page:944-950
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Ademi Zanfina¹,Kim Hansoo¹,Zomer Ella²,Reid Christopher M.²,Hollingsworth Bruce³,Liew Danny¹

Affiliation:

1. Melbourne EpiCentre; Department of Medicine (Royal Melbourne Hospital); The University of Melbourne; Melbourne; Victoria; Australia

2. Department of Epidemiology and Preventive Medicine; Monash University; Clayton; Victoria; Australia

3. Division of Health Research; Lancaster University; Lancaster; UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2012.04421.x/fullpdf

Reference17 articles.

1. Epidemiological modelling (including economic modelling) and its role in preventive drug therapy;Liew;MJA,2002

2. A model for undertaking effectiveness and cost-effectiveness analyses of primary preventive strategies in cardiovascular disease;Liew;Eur J Cardiovasc Prev Rehabil,2006

3. Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs;Flay;Prev Med,1986

4. The Role of Cost-effectiveness analysis in health and medicine;Russell;JAMA,1996

5. The potential use of decision analysis to support shared decision making in the face of uncertainty: the example of atrial fibrillation and warfarin anticoagulation. Qual Health Care;Robinson;Qual Health Care,2000

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacoeconomic Evaluation of Conservative and Interventional Management in patients with Coronary Artery Disease: Real World Data;Research Journal of Pharmacy and Technology;2024-05-15

2. Cost-effectiveness analysis of 11 pharmacotherapies for recurrent glioblastoma in the USA and China;Therapeutic Advances in Medical Oncology;2024-01

3. The Cost-Effectiveness of Dolutegravir in Combination with Tenofovir and Lamivudine for HIV Therapy: A Systematic Review;ClinicoEconomics and Outcomes Research;2024-01

4. Cost-effectiveness analysis of lifestyle interventions for preventing kidney disease in patients with type 2 diabetes;Clinical and Experimental Nephrology;2023-05-17

5. Economic Evaluation of the Community Benefit of the Australian Pregnancy Register of Antiseizure Medications;Neurology;2023-03-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3